Mesa Biotech: Mesa Biotech to Receive Additional $13 Million from US Health and Human Services to Develop 30 Minute SARS-CoV-2 & Flu A/Flu B Test

Mesa Biotech, developers of an affordable, easy to use, handheld testing platform for infectious disease diagnosis, today announced it has been awarded a contract up to $13 million from the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at the US Department of Health and Human Services (HHS)